| Neoadjuvant Chemotherapy Plus Cadonilimab for Locally Advanced Cervical Cancer (NCT07104149) | The First Affiliated Hospital of Zhengzhou University | 2025-03-10 |
| Therapeutic Effect of Upadacitinib in Primary Sjögren's Syndrome (NCT06862284) | Peking University People's Hospital | 2025-03-10 |
| Clinical Study of Geranium Wilfordii Combined With Androgen Deprivation in Neoadjuvant Therapy of Prostate Cancer (NCT06861166) | baotai Liang | 2025-03-10 |
| 177Lu-DOTATATE for Recurrent Meningioma (NCT06326190) | European Organisation for Research and Treatment of Cancer - EORTC | 2025-03-10 |
| Effects of Metformin on Hepatic Venous Pressure Gradient in Patients With Cirrhosis and Portal Hypertension (NCT06687265) | Assistance Publique - Hôpitaux de Paris | 2025-03-10 |
| Hypofractionated Radiotherapy Combined With NALIRIF, PD-1 Antibody in Locally Recurrent Rectal Cancer(NOVELTY-R) (NCT07183865) | Fudan University | 2025-03-09 |
| Metformin as a Metabolic Intervention in Oesophageal Adenocarcinomas to Improve Response to Neoadjuvant Chemoradiotherapy (NCT06687876) | Amsterdam UMC, location VUmc | 2025-03-09 |
| Pucotenlimab Combined with MRG002 for HER2-positive Cancer of Unknown Primary (NCT06869174) | Zhiguo Luo, MD, PhD | 2025-03-08 |
| Evaluation of the Safety and Efficacy of Live ASCs in the Treatment of Diabetic Foot (FOOTCELL) (NCT06843122) | Medical University of Warsaw | 2025-03-08 |
| Prospective Phase II Clinical Study of Neoadjuvant Chemoradiotherapy Combined With PD-1/PD-L1 Inhibitors in the Treatment of Locally Advanced Resectable Esophageal Squamous Cell Carcinoma (NCT06888531) | Henan Cancer Hospital | 2025-03-08 |
| Multicenter Single-Arm Study of Ivonescimab (AK112) Combined with Chemotherapy in Pretreated Pleural Mesothelioma (NCT06875076) | The First Hospital of Jilin University | 2025-03-08 |
| A Phase II Clinical Study of SHR-1826 for Injection in Patients With NSCLC (NCT06844474) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2025-03-07 |
| The Effects of One-time Intraoperative Methadone During Laparoscopic Hysterectomy in Reducing Opioid Prescription. (NCT06536517) | Johns Hopkins University | 2025-03-07 |
| A Study of Fluorescein Sodium in People Undergoing Vulvectomy for Extramammary Paget's Disease (EMPD) (NCT06873815) | Memorial Sloan Kettering Cancer Center | 2025-03-07 |
| A Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant Women (NCT06592586) | Minervax ApS | 2025-03-07 |
| A Chatbot To Support Substance Use Recovery (NCT06845878) | Dimagi Inc. | 2025-03-07 |
| A Study of VRC07-523LS, PGT121.414.LS, and PGDM1400LS Broadly Neutralizing Monoclonal Antibodies Given Intravenously in Adult Participants Without HIV (NCT06812494) | National Institute of Allergy and Infectious Diseases (NIAID) | 2025-03-07 |
| Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer (NCT06728072) | Virginia Commonwealth University | 2025-03-07 |
| Intrathecal Combination of Programmed Death-1 (PD-1)/Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) Bispecific Antibody and Pemetrexed for Leptomeningeal Metastasis (NCT06762080) | Guangzhou Medical University | 2025-03-07 |
| A Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of TERN-601 in Adults With Overweight or Obesity (NCT06854952) | Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2025-03-07 |
| Induced Pluripotent Stem Cells-derived Small Extracellular Vesicles May Promote Neurological Function and Improve Cognitive Impairment in Acute Ischemic Stroke Patients (NCT07145294) | Hongmei Wang | 2025-03-07 |
| QL1706 Plus Chidamide, AG as First-line Treatment for Metastatic Pancreatic Cancer (NCT06951997) | Tianjin Medical University Cancer Institute and Hospital | 2025-03-07 |
| A Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 (Influenza and COVID-19) Vaccine in Adults ≥18 to <65 Years of Age (NCT06864143) | ModernaTX, Inc. | 2025-03-07 |
| A Study of AMDX-2011P in Participants With Alzheimer's Disease (NCT06514001) | Amydis Inc. | 2025-03-07 |
| Phase 2 Study of ALXN2030 in Patients With Antibody-Mediated Rejection After Kidney Transplantation (NCT06744647) | Alexion Pharmaceuticals, Inc. | 2025-03-07 |
| Personalized Reduction of Chemotherapy Intensity Through ctDNA Evaluation for the Treatment of Patients With Advanced Hodgkin Lymphoma (NCT06745076) | University of Washington | 2025-03-06 |
| A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer (NCT06521567) | GlaxoSmithKline | 2025-03-06 |
| Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations (NCT06772623) | AbbVie | 2025-03-06 |
| Stereotactic Ablative Radiotherapy (XRT) and Immunotherapy for Oligometastatic Extracranial Melanoma (NCT06767306) | Melanoma Institute Australia | 2025-03-06 |
| Fucoidan for Preventing Chemotherapy-Related Fatigue in Patients With Gastrointestinal or Gynecological Cancer (NCT06855524) | Mayo Clinic | 2025-03-06 |
| Glucagon-Like Peptide-1 Receptor Agonist in ADPKD (NCT06582875) | University of Colorado, Denver | 2025-03-06 |
| A Study of MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without Diabetes (NCT06924320) | Pfizer | 2025-03-06 |
| Atezolizumab and Chemotherapy Treatment as T-cell Activators in Metastatic Triple Negative Breast Cancer Patients (NCT06690840) | European Institute of Oncology | 2025-03-06 |
| Study of CMTS1215 Injection in Patients With Solid Tumors (NCT07556276) | The Second Hospital of Nanjing Medical University | 2025-03-06 |
| Embryonal Tumor With Multilayered Rosettes (NCT06861244) | University of California, San Francisco | 2025-03-06 |
| Castrate Resistant Prostate Cancer Enhertu Therapy (NCT06610825) | Washington D.C. Veterans Affairs Medical Center | 2025-03-05 |
| A Phase 1b Study of the NLRP3 Inhibitor VENT-02 in Patients With Mild to Moderate Parkinson's Disease (NCT06822517) | Ventus Therapeutics U.S., Inc. | 2025-03-05 |
| Study of Obeldesivir to Treat Children With Respiratory Syncytial Virus (RSV) Infection (NCT06784973) | Gilead Sciences | 2025-03-05 |
| Efficacy of a Smartphone-Based JITAI to Reduce Drinking Among Adults Experiencing Homelessness (NCT06821295) | University of Oklahoma | 2025-03-05 |
| Azenosertib in Uterine Serous Carcinoma: Biomarker Study (NCT06369155) | Joyce Liu, MD | 2025-03-05 |
| Dose-Ranging Safety, Tolerability, and Efficacy Study of AZD2373 in Participants With APOL1-Mediated Kidney Disease (NCT06824987) | AstraZeneca | 2025-03-05 |
| Neoadjuvant Lu-177-PSMA-617 in Patients With High Risk Localized Prostate Cancer Undergoing Radical Prostatectomy (NCT06798558) | Hackensack Meridian Health | 2025-03-05 |
| Rilonacept in Subjects With Cardiac Sarcoidosis (NCT06660732) | Mayo Clinic | 2025-03-05 |
| Bio-Integrative, Fiber-Reinforced Kneebar for Treating Subchondral Insufficiency of the Knee (NCT06423378) | Vanderbilt University Medical Center | 2025-03-05 |
| A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma (NCT06806033) | Hoffmann-La Roche | 2025-03-05 |
| Perioperative NALIRIFOX (liposomal Irinotecan in Combination with Fluorouracil, Leucovorin, and Oxaliplatin) in Resectable Pancreatic Adenocarcinoma: Randomized Phase II Trial (NCT06816914) | Taichung Veterans General Hospital | 2025-03-05 |
| Study of Circular RNA Treatment in Patients With Radiation Induced Xerostomia-1 (NCT06714253) | RiboX Therapeutics Ltd. | 2025-03-05 |
| Pembrolizumab for the Treatment of Locally Advanced and/or Recurrent Orbital or Periocular Cutaneous Squamous Cell Carcinoma (NCT06580054) | University of Michigan Rogel Cancer Center | 2025-03-05 |
| Psilocybin for Enhanced Analgesia in Chronic nEuropathic PAIN (NCT06731335) | Unity Health Toronto | 2025-03-05 |
| A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Elismetrep (K-304) in the Treatment of Migraine (NCT06848075) | Kallyope Inc. | 2025-03-05 |
| A Phase 1B/2A Trial of NADUNOLIMAB in Combination With Azacitidine (With/Without Venetoclax) in Patients With Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML) (NCT06548230) | M.D. Anderson Cancer Center | 2025-03-05 |
| IL-1 Inhibition in Early TNBC (NCT06710197) | University Health Network, Toronto | 2025-03-05 |
| TriCalm Hydrogel® in the Treatment of Immunotherapy-Related Pruritus (NCT06748404) | University of California, San Diego | 2025-03-05 |
| Local Antibiotic Delivery for Community Acquired Pneumonia (NCT06859450) | Copenhagen Respiratory Research | 2025-03-04 |
| A Study of Setmelanotide in Patients With Prader-Willi Syndrome (NCT06772597) | Rhythm Pharmaceuticals, Inc. | 2025-03-04 |
| Ketamine-Assisted Recovery for Methamphetamine Use Disorder & HIV (NCT06538285) | Nicky Mehtani, MD, MPH | 2025-03-04 |
| Neoadjuvant High-Intensity Focused Ultrasound (HIFU) Combined With Toripalimab and Chemotherapy for ER-Positive /HER2-Negative Breast Cancer (NCT06964906) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2025-03-04 |
| A Study of Mocertatug Rezetecan in Combination With Anti-cancer Therapies for Advanced Solid Tumors (BEHOLD-2) (NCT06796907) | GlaxoSmithKline | 2025-03-04 |
| Nasal Foralumab in Patients With Non-Active Secondary Progressive Multiple Sclerosis (NCT06890923) | Tiziana Life Sciences LTD | 2025-03-04 |
| Slow Wave Induction by Propofol to Eliminate Depression (SWIPED) Stage II (NCT06867549) | Washington University School of Medicine | 2025-03-04 |
| A Study of TYRA-300 in Children With Achondroplasia: BEACH301 (NCT06842355) | Tyra Biosciences, Inc | 2025-03-04 |
| Suicide Risk Interventions (NCT05931289) | VA Office of Research and Development | 2025-03-03 |
| Hippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastases From Breast Cancer or Non-small Cell Lung Cancer (NCT06518057) | University of Washington | 2025-03-03 |
| A Study to Evaluate ALN-4324 in Overweight to Obese Healthy Volunteers and in Overweight to Obese Patients With T2DM (NCT06845202) | Alnylam Pharmaceuticals | 2025-03-03 |
| A Study of Microbiome Transplantation for the Treatment of Constipation and/or Significant Bloating in Patients With Systemic Sclerosis (NCT06827977) | The University of Texas Health Science Center, Houston | 2025-03-03 |
| Scrambler Therapy With Duloxetine-based Usual Care vs Duloxetine-based Usual Care for Chemotherapy-induced Peripheral Neuropathy. (NCT06914557) | Fox Chase Cancer Center | 2025-03-03 |
| Clinical Study on the Safety and Efficacy of BCMA-CART±ASCT in Treating Young Multiple Myeloma Patients (NCT07169500) | Institute of Hematology & Blood Diseases Hospital, China | 2025-03-03 |
| Impact of Cannabinoids on Menopause Symptoms (NCT06831916) | Washington State University | 2025-03-03 |
| Neoadjuvant Intralesional Injection of Talimogene Laherparepvec (NCT06660810) | John Rieth | 2025-03-03 |
| Safety and Preliminary Efficacy of Pumitamig (BNT327), an Investigational Therapy for Patients With Non-small Cell Lung Cancer in Combination With Chemotherapy as First-line or Second-line Treatment (NCT06841055) | BioNTech SE | 2025-03-03 |
| VY7523-102: Randomized, Placebo-Controlled, Double-Blind, Multiple Ascending Dose Study in Participants With Early Alzheimer's Disease (NCT06874621) | Voyager Therapeutics | 2025-03-03 |
| A Phase 2 Study of YA-101 in Patients With Multiple System Atrophy (NCT06848231) | Dasher Neuroscience Inc. | 2025-03-03 |
| A Study of the Early Effects, Safety, and Acceptability of Oral Alpibectir in Combination With Ethionamide (NCT06748937) | TASK Applied Science | 2025-03-03 |
| Optimized Cord Blood Transplantation for the Treatment of Patients With High-risk Hematologic Malignancies Who Have Relapsed After First Allogeneic Stem Cell Transplantation (NCT06807606) | M.D. Anderson Cancer Center | 2025-03-03 |
| A Phase II Clinical Study to Evaluate HLX43 in Patients With Locally Advanced or Metastatic HCC Failed or Intolerance to Standard Therapy (NCT06742892) | Shanghai Henlius Biotech | 2025-03-03 |
| Autologous Transplantation Combined With BCMA CAR-T in the Treatment of UHR-MM (NCT07109323) | Institute of Hematology & Blood Diseases Hospital, China | 2025-03-03 |
| An Open, Exploratory Clinical Study of CM336 in the Treatment of Immune Thrombocytopenia (NCT06799611) | Institute of Hematology & Blood Diseases Hospital, China | 2025-03-03 |
| Bemarituzumab in FGFR2b+ Patients With Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction, Who Failed at Least One Prior Line of Palliative Chemotherapy (NCT06680622) | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 2025-03-03 |
| Dexamethasone Versus Dexmedetomidine in IPACK Block to Reduce Pain Post Arthroscopic Knee Surgeries (NCT07024043) | Ain Shams University | 2025-03-03 |
| A Clinical Study on the Efficacy and Safety of Herombopag in the Treatment of Senile Primary ITP (NCT06838949) | Institute of Hematology & Blood Diseases Hospital, China | 2025-03-03 |
| Newly-diagnosed Low Risk Pediatric B-cell ALL Protocol (NCT06882057) | Institute of Hematology & Blood Diseases Hospital, China | 2025-03-03 |
| Daily Doxycycline for Early Syphillis (NCT06683638) | University of Washington | 2025-03-03 |
| Whole Body HER3 Quantification With Radiolabelled Patritumab Deruxtecan (HER3-DXd) PET/CT (NCT06222489) | The Netherlands Cancer Institute | 2025-03-03 |
| Anti-CD25 rhMAb for aGVHD Prevention in High-Risk Adults Using the daGOAT Model (NCT06880419) | Institute of Hematology & Blood Diseases Hospital, China | 2025-03-03 |
| Study of Zelenectide Pevedotin in Participants With Advanced Breast Cancer (NCT06840483) | BicycleTx Limited | 2025-03-03 |
| Low Dose Teclistamab in Newly Diagnosed Multiple Myeloma Patients (NCT06758375) | Hospital Universitario Dr. Jose E. Gonzalez | 2025-03-03 |
| Therapeutic Effect of Proliferative Therapy (Prolotherapy) on Pain Using Injectable Hypertonic Dextrose 25% Versus Injectable Dextrose 10% in Retrodiscal Tissues in Patients With Anterior Disc Displacement With Reduction: A Randomized Clinical Trial . (NCT06859034) | Cairo University | 2025-03-03 |
| Effect of Probiotics "Psychobiotics" on Depression and Metabolic Syndrome in Saudi Arabia (NCT06765057) | Roaa Ahmed Alkreadees | 2025-03-02 |
| Clinical Trial of TQB3702 Tablets in Subjects With Systemic Lupus Erythematosus (SLE) (NCT06859931) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2025-03-01 |
| Medication Withdrawal in Stable HF With Improved LVEF (NCT07489547) | Hospital de Clinicas de Porto Alegre | 2025-03-01 |
| MDMA-Assisted Therapy for Veterans With Moderate to Severe Post Traumatic Stress Disorder (NCT05790239) | Stephen Robert Marder | 2025-03-01 |
| A Study of the Safety and Efficacy of Pemetrexed Combined with Nivolumab Via Intraventricular Injection for the Treatment of Refractory Non-squamous Non-small Cell Lung Cancer with Leptomeningeal Metastases (NCT06901817) | Shanghai Cancer Hospital, China | 2025-03-01 |
| Trial of Gum Chewing to Enhance the Restoration of Intestinal Motility in Colorectal Cancer Surgery (NCT06860685) | Sichuan Cancer Hospital and Research Institute | 2025-03-01 |
| Efficacy and Safety of Yttrium-90 Microspheres Selective Internal Radiotherapy Combined with Immune Checkpoint Inhibitors and Anti-angiogenesis Drugs Sequential HAIC for Hepatocellular Carcinoma (NCT06867432) | Tianjin Medical University Cancer Institute and Hospital | 2025-03-01 |
| Neoadjuvant Ivonescimab and Chemotherapy in Resectable Esophageal Cancer (NCT06814158) | Tianjin Medical University Cancer Institute and Hospital | 2025-03-01 |
| Evaluating the Safety and Efficacy of Carbocisteine in the Treatment of Nonalcoholic Fatty Liver Disease Patients (NCT06863376) | Tanta University | 2025-03-01 |
| Phase I/II, Open Label, Randomized, Safety and Immunogenicity Following DTwP-Hepatitis B-Hib-IPV Vaccine (Bio Farma) in Indonesian Infants (NCT06690515) | PT Bio Farma | 2025-03-01 |
| Study of CM313(SC) Injection in Subjects With Relapsed/Refractory Aplastic Anemia (NCT06791824) | Keymed Biosciences Co.Ltd | 2025-03-01 |
| The Transendocardial Autologous Cells (hMSC) or (hMSC) and (hCSC) in Ischemic Heart Failure Trial. (NCT02503280) | Joshua M Hare | 2025-03-01 |
| A Clinical Study Comparing Chemotherapy Combined With PD-1 Inhibitor Versus Concurrent Chemoradiotherapy in Cervical Cancer Patients With Positive Lymph Nodes After Surgery: A Multicenter Randomized Controlled Clinical Trial (NCT06866951) | Women's Hospital School Of Medicine Zhejiang University | 2025-03-01 |